Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Consortium for the Study of Cerebellar Ataxias (CRC-SCA) for the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias (SCA)

NCT01060371 is registered in ClinicalTrials.gov with Lauren Moore as lead sponsor.

NCT NCT01060371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Consortium for the Study of Cerebellar Ataxias (CRC-SCA) for the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias (SCA)
Lead sponsor
Lauren Moore
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2010
Completion date
December 31, 2030
Enrollment
1,400 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants, rfc1 gene mutation, spinocerebellar ataxia type 1, spinocerebellar ataxia type 10, spinocerebellar ataxia type 2, spinocerebellar ataxia type 27b, spinocerebellar ataxia type 3, spinocerebellar ataxia type 6, spinocerebellar ataxia type 7, spinocerebellar ataxia type 8